Definitive Healthcare Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020
Net Income	-202.39	-7.22	-17.84	0
Depreciation & Amortization	51.75	56.9	59.95	59.58
Share-Based Compensation	48.74	36.43	9.96	1.75
Other Operating Activities	143.09	-50.54	-26.85	-38.11
Operating Cash Flow	41.19	35.58	25.21	23.22
Operating Cash Flow Growth	15.77%	41.12%	8.59%	-
Capital Expenditures	-2.98	-8.33	-6.73	-1.4
Acquisitions	-45.02	-56.3	-40	-22.47
Change in Investments	16.22	-184.28	0	0
Investing Cash Flow	-31.78	-248.9	-46.73	-23.86
Share Issuance / Repurchase	0	0	834.95	0
Debt Issued / Paid	-8.59	-6.88	-202.97	13.23
Other Financing Activities	-16.99	-19.82	-247.61	3.43
Financing Cash Flow	-25.58	-26.7	384.37	16.66
Exchange Rate Effect	0.22	-0.54	-0.13	0.15
Net Cash Flow	-16.18	-240.02	362.85	16.01
Free Cash Flow	38.21	27.25	18.48	21.82
Free Cash Flow Growth	40.22%	47.46%	-15.31%	-
Free Cash Flow Margin	15.20%	12.24%	11.12%	18.44%
Free Cash Flow Per Share	0.34	0.27	0.20	0.17

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).